Bristol-Myers Squibb to acquire Celgene in $74B deal

Bristol-Myers Squibb to acquire Celgene in $74B deal

The acquisition brings together two of the largest drugmakers in the country, both of which are major players in biopharma, particularly oncology.

Source: http://bit.ly/2BVjXB6